Stolba et al., 2004 - Google Patents
The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitutionStolba et al., 2004
- Document ID
- 7741733502342129167
- Author
- Stolba U
- Krepler K
- Velikay-Parel M
- Binder S
- Publication year
- Publication venue
- Graefe's Archive for Clinical and Experimental Ophthalmology
External Links
Snippet
Purpose To evaluate the histological changes in the retina after experimental vitreous substitution with various amounts of perfluorophenanthrene (PFPH). Methods Thirty-two rabbit eyes were mechanically vitrectomized and filled up with 0.8 cc or 0.2 cc highly purified …
- 210000001525 Retina 0 title abstract description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sandner et al. | First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment | |
Klein et al. | Postoperative complications and visual outcomes of phacoemulsification in 103 dogs (179 eyes): 2006–2008 | |
Martin et al. | Ophthalmic disease in veterinary medicine | |
Holland et al. | Ocular Surface Disease: Cornea, Conjunctiva and Tear Film E-Book: Expert Consult-Online and Print | |
Agrawal et al. | In vivo models of proliferative vitreoretinopathy | |
Barth et al. | A cross-linked hyaluronic acid hydrogel (Healaflow®) as a novel vitreous substitute | |
Elsing et al. | Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid | |
Theelen et al. | Intraocular inflammation following endotamponade with high-density silicone oil | |
Stolba et al. | The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution | |
Sandner et al. | High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up | |
Wilkie et al. | Canine cataracts, diabetes mellitus and spontaneous lens capsule rupture: a retrospective study of 18 dogs | |
Martins et al. | Ocular manifestations and therapeutic options in patients with familial amyloid polyneuropathy: a systematic review | |
Czajka et al. | Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole | |
Toyama et al. | Visual acuity improvement after phacoemulsification cataract surgery in patients aged≥ 90 years | |
Mackiewicz et al. | Effect of gravity in long-term vitreous tamponade: in vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes | |
Longo et al. | Long-term effect of phacoemulsification on trabeculectomy function | |
Spiess | Equine recurrent uveitis: the European viewpoint | |
Williams et al. | Current concepts in the management of canine cataract: a survey of techniques used by surgeons in Britain, Europe and the USA and a review of recent literature | |
Gemensky‐Metzler et al. | Retrospective study of the prevalence of keratoconjunctivitis sicca in diabetic and nondiabetic dogs after phacoemulsification | |
Newbold et al. | Phacoemulsification outcomes in Boston terriers as compared to non‐Boston terriers: a retrospective study (2002–2015) | |
Cichocki et al. | Modified penetrating keratoplasty with Acell® bioscaffold implant in seven horses with deep full‐thickness corneal stromal abscess | |
Semeraro et al. | Tamponade or filling effect: changes of forces in myopic eyes | |
Leasure et al. | The relationship of cataract maturity to intraocular pressure in dogs | |
Crafoord et al. | Experimental vitreous tamponade using polyalkylimide hydrogel | |
Harrington et al. | Phacoemulsification and+ 14 diopter intraocular lens placement in a Saddlebred foal |